Correlation Between Visa and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Mydecine Innovations Group, you can compare the effects of market volatilities on Visa and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Mydecine Innovations.

Diversification Opportunities for Visa and Mydecine Innovations

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Visa and Mydecine is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Visa i.e., Visa and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Visa and Mydecine Innovations

Taking into account the 90-day investment horizon Visa is expected to generate 52.23 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, Visa Class A is 35.47 times less risky than Mydecine Innovations. It trades about 0.07 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  0.50  in Mydecine Innovations Group on September 24, 2024 and sell it today you would lose (0.10) from holding Mydecine Innovations Group or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Visa Class A  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly inconsistent basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Visa and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Mydecine Innovations

The main advantage of trading using opposite Visa and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Visa Class A and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals